Skip to main content
SpringerLink
Log in

Responses to Epstein-Barr Virus in Immune Deficient Patients

  • Chapter
Immune Deficiency and Cancer

Abstract

Two decades have passed since Epstein-Barr virus (EBV) was described (1) and yet new diseases continue to be attributed to the virus. Debates initiated in the early 1960’s are ongoing regarding the role of the virus in Burkitt lymphoma (BL), and nasopharyngeal carcinoma (NPC). Recently, the opportunistic malignant lymphomas (ML) occurring in immune deficient individuals have provided new puzzles. Questions remaining to be answered are whether latent virus is activated in B cells transformed by other agents or alternatively, does the virus infect the malignant B cell after transformation owing to the presence of viral receptors on the cell. Attention has also been directed to find oncogenic and benign strains of the virus. In our view, underlying inherited or environmentally induced immune deficiency is important in determining the outcome of EBV infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Epstein, M.A., Achong, B.G., and Barr, Y.M. Virus particles in cultured lymphoblasts from Burkitt’s Lymphoma. Lancet, i:702–703, 1964.

    Article  Google Scholar 

  2. Purtilo, D.T. X-linked lymphoproliferative syndrome: an immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis or malignant lymphoma. Arch. Path. Lab. Med., 106:119, 1981.

    Google Scholar 

  3. Henle, W., Henle, G., and Lennette, E.T. Epstein-Barr virus. Sci. Am., 241:48, 1979.

    Article  PubMed  CAS  Google Scholar 

  4. Niederman, J.C. Prevalence, incidence and persistence of EB virus antibody in young adults. N. Engl. J. Med., 282:361, 1970.

    Article  PubMed  CAS  Google Scholar 

  5. Tosato, G., Magrath, I., Koski, I., Dooley, N., and Blaese, M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N. Engl. J. Med., 301:1133, 1979.

    Article  CAS  Google Scholar 

  6. Klein, G., Svedmyr, E., Jondal, M., and Persson, P.O. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int. J. Cancer, 17:21, 1976.

    Article  PubMed  CAS  Google Scholar 

  7. Robinson, J.E., Smith, D., and Niederman, J. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis. J. Exp. Med., 153:235, 1980.

    Article  Google Scholar 

  8. Epstein-Barr Virus. Editors, M.A. Epstein and B. Achong, Springer-Verlag, Berlin, 1979.

    Google Scholar 

  9. Purtilo, D.T. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections. In: S.C. Sommers and P.P. Rosen (eds.), Pathology Annual, 1980. pp. 253–299. New York: Appleton-Century-Crofts, 1980.

    Google Scholar 

  10. Purtilo, D.T., DeFlorio, D., Hutt, L.M., Bhawan, J., Yang, J.P.S., Otto, R., and Edwards, W. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N. Engl. J. Med., 297:1077, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Purtilo, D.T., Paquin, L.A., DeFlorio, D., Virzi, F., and Sukhuja, R. Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome. Sem. Hematol. 16:309, 1979.

    CAS  Google Scholar 

  12. Purtilo, D.T. Hypothesis: pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome. Lancet, ii:882, 1976.

    Article  Google Scholar 

  13. Purtilo, D.T., Sakamoto, K., Barnabei, V., Seeley, J., Bechtold, T., Rogers, G., Yetz, J., and Harada, S. Epstein-Barr virus-induced diseases in males with the X-linked lymphoproliferative syndrome (XLP). Am. J. Med., 73: 49, 1982.

    Article  PubMed  CAS  Google Scholar 

  14. Purtilo, D.T., Sakamoto, K., Saemundsen, A.K., Sullivan, J.L., Synnerholm, A.C., Andersson-Anvret, M., Pritchard, J., Sloper, C., Sieff, Collins, R., Barnes, N., Knight, J., Sandstedt, B., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative disease by clinical, virological and immunopathological studies. Cancer Res., 41:4226, 1981.

    PubMed  CAS  Google Scholar 

  15. Saemundsen, A.K., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Synnerholm, A.C., Hanto, D., Simmons, R., Anvret, M., Collins, R., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res., 41:4237, 1981.

    PubMed  CAS  Google Scholar 

  16. Seeley, J.K., Sakamoto, K., Ip, S., Hansen, P., and Purtilo, D.T. Abnormal subsets in the X-linked lymphoproliferative syndrome. J. Immunol., 127:2618, 1981.

    PubMed  CAS  Google Scholar 

  17. Purtilo, D.T., Yang, J.P.S., Cassel, C.K., Harper, P., Stephenson, S.R., Landing, B.H. and Vawter, G.F. X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet, i: 935, 1975.

    Article  Google Scholar 

  18. Lindsten, T., Seeley, J.K., Sakamoto, K., Yetz, J., Harada, S., Bechtold, T., Rogers, G., and Purtilo, D.T. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects. J. Immunol., 129:2536, 1982.

    PubMed  CAS  Google Scholar 

  19. Ochs, H.D., Sullivan, J.L., Wedgewood, R.J., Seeley, J.K., Sakamoto, K., and Purtilo, D.T. X-linked lymphoprolifer-ative syndrome: abnormal antibody responses to bacteriophage ØX174. In: R. Wedgewood and F. Rosen (eds.), Primary Immunodeficiency Diseases. New York: Alan R Liss, 1983.

    Google Scholar 

  20. Seeley, J.K., Harada, S., Bechtold, T., Ochs, H.D., Wedgewood, R.J., Sakamoto, K., Lindsten, T., Yetz, J., and Purtilo, D.T. Primary and acquired immune defects in X-linked lymphoproliferative syndrome. In preparation.

    Google Scholar 

  21. Harada, S., Bechtold, T., and Purtilo, D.T. Comparison of long-term T-cell-mediated immunity to Epstein-Barr virus and NK cell-activity in obligate carrier females and males with the X-linked lymphoproliferative syndrome. Int. J. Cancer, 216:739, 1982.

    Article  Google Scholar 

  22. Szigeti, R., Masucci, M.G., Henle, W., Henle, G, Purtilo, D.T., and Klein, G. Effects of different EBV-determined antigens (EBNA, EA and VCA) on mononucleosis and certain immunodeficiencies. Clin. Immunol. Immunopath., 22:128, 1982.

    Article  CAS  Google Scholar 

  23. Sullivan, J.L., Byron, K., Brewster, F., and Purtilo, D.T. Deficient natural killer cell activity in the X-linked lymphoproliferative syndrome. Science, 210:543, 1981.

    Article  Google Scholar 

  24. Purtilo, D.T. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. In: G. Klein and S. Weinhouse (eds.), Advances in Cancer Research. Vol. 34, pp. 279–312. New York: Academic Press, 1980.

    Google Scholar 

  25. Sakamoto, K., Freed, H., and Purtilo, D.T. Antibody re sponses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J. Immunol., 125:921, 1980.

    PubMed  CAS  Google Scholar 

  26. Sakamoto, K., Seeley, J.K., Lindsten, T., Sexton, J., Yetz, J., Ballow, M., and Purtilo, D.T. Abnormal anti-Epstein-Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J. Immunol., 128:904, 1982.

    PubMed  CAS  Google Scholar 

  27. Seeley, J.K., Bechtold, T., Lindsten, T., and Purtilo, D.T. NK deficiency in X-linked lymphoproliferative syndrome. In: R.B. Herberman (ed.), Natural Cell Mediated Immunity 1982. Vol. 2, pp. 1211–1218. New York: Academic Press, 1982.

    Google Scholar 

  28. Rickinson, A.B., Moss, D.J., Wallace, L.E., Rowe, M., Misko, I.S., Epstein, M.A., and Pope, J.H. Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res., 41:4216, 1981.

    PubMed  CAS  Google Scholar 

  29. Purtilo, D.T. and Sullivan, J.L. Immunological bases for superior survival of females. Am. J. Dis. Child., 133:1251, 1979.

    PubMed  CAS  Google Scholar 

  30. Klein, G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc. Natl. Acad. Sci., 76: 2442, 1979.

    Article  PubMed  CAS  Google Scholar 

  31. Rowley, J.D. Identification of the constant chromosome regions involved in human hematologic malignant disease. Science, 216: 794, 1982.

    Article  Google Scholar 

  32. Kersey, J.H. and Spector, B.D. Immune deficiency disease. In: J. F. Fraumeni, Jr. (ed.), Persons at High Risk of Cancer: An Approach to Cancer Etiology and Control, pp. 55–67. New York: Academic Press, 1975.

    Google Scholar 

  33. Saemundsen, A.K. Epstein-Barr virus-carrying lymphoma in a patient with ataxia-telangiectasia. Brit. Med. J., 282:425, 1981.

    Article  CAS  Google Scholar 

  34. Purtilo, D.T., Liao, S.A., Sakamoto, K., Snyder, L.M., DeFlorio, D., Bhawan, J., Paquin, L.A., Yang, J.P.S., Hutt-Fletcher, L.M., Muralidharan, K., Raffa, P., Saemundsen, A.K., and Klein, G. Diverse familial malignant tumors and Epstein-Barr virus. Cancer Res., 41:4248, 1981.

    PubMed  CAS  Google Scholar 

  35. Penn, I. Depressed immunity and the development of cancer. Clin. Exp. Immunol., 46:459–474, 1981.

    PubMed  CAS  Google Scholar 

  36. Hanto, D.W., Frizzera, G., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Saemundsen, A.K., Klein, G., Simmons, R.L., and Najarian, J.S. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res., 41:4253, 1981.

    PubMed  CAS  Google Scholar 

  37. Hanto, D.W., Frizzera, G., Gajl-Peczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H., Simmons, R.L., and Najarian, J.S. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med., 306:913, 1982.

    Article  PubMed  CAS  Google Scholar 

  38. Bieber, C. Lymphoma in cardiac transplant recipients associated with cyclosporin A, prednisone, and anti-thymocyte globulin (ATG). In: D.T. Purtilo (ed.), Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies. New York: Plenum Press, in press.

    Google Scholar 

  39. Reece, E.R., Gartner, J.G., Seemayer, T.A., Joncas, J.H. and Pagano, J.S. Epstein-Barr virus in a malignant lympho-proliferative disorder of B cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res., 41:4243, 1981.

    PubMed  CAS  Google Scholar 

  40. Schubach, W.H., Hackman, R., Neiman, P.E., Miller, G., Thomas, E.D. Blood, in press.

    Google Scholar 

  41. Fox, R., McMillan, R., Spruce, W., Tani, P., and Mason, D. Analysis of T lymphocytes after bone marrow transplantation using monoclonal antibodies. Blood, 60:578, 1982.

    PubMed  CAS  Google Scholar 

  42. Look, A.T., Naegle, R.F., Calihan, T., Herrod, H.G., and Henle, W. Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission. Cancer Res., 41:4280, 1981.

    PubMed  CAS  Google Scholar 

  43. Hardy, C., Harada, S., Lubin, B., Sanger, W., von Schmidt, B., Yetz, J., Saemundsen, A.K., Feusner, J., Lennette, E., Linder, J., Seeley, J.K., and Purtilo, D.T. Epstein-Barr virus (EBV) induced lymphoproliferation complicating acute lymphoblastic leukemia. J. Peds., in press.

    Google Scholar 

  44. Sonnabend, J., Witkin, S.S., and Purtilo, D.T. Acquired immunodeficiency syndrome (AIDS), opportunistic infections and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis. J. Am. Med. Assoc, 249:2370, 1983.

    Article  CAS  Google Scholar 

  45. Zeigler, J.L., Wagner, G., and Greenspan, J.S. Diffuse, Undifferentiated, non-Hodgkin’s lymphoma in homosexual male — United States. Morbidity and Mortality Weekly Report, 31:277, 1982.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology & Laboratory Medicine, University of Nebraska Medical Center, Omaha, NE, 68105, USA

    Shinji Harada, Eiji Tatsumi, Helen Lipscomb & David T. Purtilo

Authors
  1. Shinji Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Tatsumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helen Lipscomb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David T. Purtilo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Nebraska Medical Center, Omaha, Nebraska, USA

    David T. Purtilo

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Publishing Corporation

About this chapter

Cite this chapter

Harada, S., Tatsumi, E., Lipscomb, H., Purtilo, D.T. (1984). Responses to Epstein-Barr Virus in Immune Deficient Patients. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4760-6_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4762-0

  • Online ISBN: 978-1-4684-4760-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation